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SPECIFIC RELATIONSHIP OF CELL COM­
POSJTION TO BIOLOGICAL ACTIVITY 
OF HEMOLYTIC STREPTOCOCCP 
REBECCA C. LANCEFIELD 
Associate, The Rockefeller Institute for Medical Research 
THE early descriptions of streptococci dealt chiefly with theirmorphology and pathogenicity, from the time when Pasteur 
(98) saw them as a chain of beads in the blood of a patient dying
of puerperal sepsis until Schottmiiller (107), in 1903, showed
that various streptococci differ in their effect on blood. He dis­
tinguished hemolytic streptococci from· Streptococcus viridans,
according to whether the microorganisms hemolyzed or produced
a greenish discoloration of the red blood cells around a colony
growing on a blood agar plate. · Mandelbaum (88), in 1907, de­
scribed Streptococcus saprophyticus, now commonly called the
indifferent streptococcus, which did not produce any visible effect
on red blood cells. These observations have been the basis for
the main differentiation of streptococci for almost forty years.
In 1919, Brown (11, 119) defined these three varieties more ex­
actly and designated them as alpha, indicating the slightly hemo­
lytic, methemoglobin producing strains; beta, those that were
markedly hemolytic; and gamma, those without visible effect on
blood.
Thus, the so-called streptolysin ( 6) is the cellular component 
of hemolytic streptococci that was first useful for classification. 
Opinions of the earlier investigators varied with regard to the 
filtrability and antigenicity of this substance, but all were unani­
mous as to its !ability. McLeod (91) agreed with some of these 
investigators in concluding that streptolysin was not antigenic. 
He established as a criterion for the production of a soluble 
hemolysin, the lysis of washed red blood cells by broth cultures 
or their filtrates. This led to some confusion in the case of those 
streptococci which hemolyzed whole sections of blood agar plates, 
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but failed to yield a "soluble hemolysin" when tested by 
McLeod's method (21, 12�, 135). Neill and Mallory (95) found 
that, like the lysins of other microorganisms which . they . had 
studied, streptolysin was subject to reversible oxidation and 
reduction. 
Todd, beginning in 1928 (128), reinvestigated.this whole ques­
tion and, in 1938 (130-132), offered a more complete explanation 
of the peculiarities of the lytic activities of hemolytic strepto­
cocci. Briefly, he found two streptolysins, streptolysin O and 
streptolysin S, with radically different prop�rties. Mixtures con­
taining different proportions of the two explained the variable 
results of earlier work. Streptolysin 0, found in serum-free 
broth culture filtrates, is subject to reversible oxidation and re­
duction. It is antigenic and combines with antibody either in 
the oxidized or reduced state, but is hemolytic only when reduced . 
.Antibodies to this streptolysin are formed in response to strepto­
coccal infections, and serve, therefore, in the study of. human 
diseases, as a useful diagnostic index of previous streptococcal 
infection. Smythe and Harris (120) concluded from chemical 
studies. of partially purified preparations that streptolysin O is 
probably protein in nature and that it contains rather large 
amounts of sulphur, part of which exists as an -SH� -S-S­
oxidation-reduction system. If the -SH groups are removed by 
oxidation or other means, the substance becomes hemolytically 
inactive. 
Todd (131) also investigated the hemotoxin described orig­
inally by Weld ( 138, 139) and distinguished a second highly 
toxic substance, streptolysin S, jn filtrates of serum broth cul­
tures and in serum extracts of streptococci prepared according 
to Weld 's technique. These preparations contaii:i much .more 
streptolysin S than streptolysin 0, but all preparations also con­
tain some streptolysin 0. Todd showed that streptolysin S 
probably represents the most active principle of the hemotoxin 
described by Weld. In contrast to the oxygen-labile streptol.ysin 
0, streptolysin Sis not apparently affected by oxidation or reduc­
tion, but is exceedingly labile to acid, and so sensitive to heat that 
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it is irreversibly inactivated by .storage even at ordinary ice-box 
temperatures, and can be preserved only at -73° C. Weld 
showf!d that extracts containing this substance are highly toxic 
for'mice; and both Weld and Hare (47) studied the pathological 
effects in animals, but were unable to correlate the lethal and 
hemolytic titers of extracts. Todd ( 130), however, explained 
this discrepancy when he found both streptolysin O and strepto­
lysin S in these extracts, and showed that these substances pro­
duced distinct pathological effects on mice (3)·. Todd found also 
that an'tibodies directed against streptolysin s· are formed in 
experimental animals only in response to immunization with liv­
ing streptococci. The antibody titers in immunized animals, and 
also ·in man following known streptococcal infections, are never 
very high but show, nevertheless, a significant increase. In 
rheumatic fever patients, Todd, Coburn and Hill (133) con­
cluded, from statistical analysis of the results of serological 
studies, that the antistreptolysin S titers of rheumatic children 
decreased during acute attacks and increased during recovery, 
in contrast to the steady rise in titer observed in non-rheumatic 
children in response to streptococcal infections or in rheumatic 
children who escaped recrudescences following streptococcal in­
fections. The low antistreptolysin S titers are also contrasted 
with the generally high level of antistreptolysin O during the 
acute phase of rheumatic fever. 
Although hemolytic activities were the foundation of the first 
· successful classifi.cation of streptococci, the results of the action
of the carbohydrate-splitting enzymes of these microorganisms
were often employed in early studies for purposes of classifica­
tion. Many investigators sought orderly arrangements of strep­
tococci by studying their fermentation reactions, by investigating
the limiting pH values for growth and viability, and by deter­
mining other biochemical and cultural' characteristics. Although
considerable progress was possible by these methods, there was
always overlapping among the classes differentiated and the
results were often difficult or impossible to interpret.
Serological classification of hemolytic streptococci was also 
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attempted early, using the agglutination reaction and the tech­
nique of agglutinin absorption. There are, however, many tech­
nical difficulties in. streptococcus agglutination reactions and, by· 
the beginning of the last war, opinion was divided as to the value 
and meaning of these results, either for the determination of 
serologically distinct types or for the differentiation of strains 
from human and animal sources (37). It was, however, finally 
established, from study of epidemic strains in Army camps in 
1918, that specific serological types existed among hemolytic 
streptococci paJhogenic for man (25). 
GROUP PHENOMENA 
Several years later, Hitchcock (59) found that, irrespective of 
the type-relationships, hemolytic streptococci isolated from a 
wide variety of human diseases all possessed in common a sero­
logically active polysaccharide. This, at the time, .seemed con­
fusing .because Heidelberger and Avery (54) had just shown that 
bacterial polysaccharides were responsible for type-specificity of 
pneumococci. The demonstration was so clear for pneumococci, 
TABLE I 
Most Characteristic Source 
Group A Man 
" B Bovine mastitis 
" C Most !!treptococcal animal diseases 
" D Originally identified as cheese strains; also entero-
cocci and other human' saprophytes 
" E Normal milk. 
" F 
" G 
" H 
" K 
''Minute'' 
} 
Large and ''minute'' Human nasopharynx 
usually non-pathogenic 
" 
�} " Chiefly dogs, recently identified by Fry* 
• Unpublished data; personal communication.
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that the same principles were thought to apply to other bacteria. 
For Streptococcus viridar,,s (60, 71), this proved true, but hemo­
lytic f?treptococci offered the first exception to this rule. 
The polysaccharide characteristic of hemolytic streptococci 
comprising a large number of strains pathogenic for man, now 
designated as Group A_, reacted· specifically with the serum of 
animals immunized with any other members of this group. How­
ever, a series of strains isolated from lower animals failed to give 
this reaction, and it was thought, therefore, that other groups of· 
streptococci might also be characterized by carbohydrates specific 
for each group. This, indeed, proved true, and several addi­
tional groups have been identified as shown in Table I, in which. 
eleven groups are designated with their most characteristic 
sources. Group A is composed of strains usually pathogenic for· 
man; Group B, of those from bovine mastitis; Group C is found. 
in a great many streptococcal diseases of lower animals; Group, 
D, originally identified in strains isolated from cheese, also in-­
eludes the so-called enterococci and other human saprophytes;· 
Group E is found in normal milk; Groups; F to K occur in the, 
human nasopharynx, usuaJly not associated with disease ; and 
Groups L and M have been recently designated by Fry, and. 
include streptococci found so far chiefly in- diseases of dogs. 
Members of most of the known groups· have, however, been. 
obtained in cultures from various parts of the human body. In. 
Table II are listed the groups, members of which have been iso­
lated from man and from other animal&. The chief pathogenic, · 
streptococci of human, bovine or equine origin are fairly well­
known: Group A, in man, Groups B and C in cattle, Group C ·in 
horses. Among guinea pigs also, Group C streptococci are­
known to be the chief pathogens, as well as among most other· 
doD?-estic and laboratory animals, with the possible exceptions of 
the monkey, the mouse, and the dog. The second column shows. 
the usual distribution of serological groups of hemolytic strepto-­
cocci in respect to disease in different animals. Occasionally, 
however, members of groups not usually pathogenic for a species. 
are isolated from undoubted infections, as shown in the third 
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TABLE II 
Pathogenicity of.Serological Groups of Hemolytic Btreptoooooi · 
-
Chief Groups 
Animal patho- Occasionally found but pathogenic apparently References source genie groups non-patho-groups genie 
?,fan A B, C, D, F, G, H, K,L 15, 18, 32, 44, 46, 
48, 51, 52, 63, 
77, 82, 105, 106, 
111 
Cattle B,C A,G D,E,H,L 28, 29, 44, 45, 85, 
, 92, 94, 97, 100, 
• 121, 123, 124 
Horse C 5, 26, 27, 28, 29, 
97 
Monkey A,G C 10, 82, 105, 110 
Dog G, L, M C 53, 82, 101 
Chicken At 28, 29, 100 
Swine E,*L G 
Goat 
Sheep �c 
Fox M 
Ferret 
Rabbit A,B 77 
Guinea Pig 
Mouse A,B,C 86 
* Strains received from Dr. Stafseth.
column ; still others have been found which have never been iso­
lated from disease (Column 4). ·More work is necessary before 
closer correlations can be established between serological groups 
and species susceptibility. 
Fatal Human Infections. Investigation of the streptococcal 
carrier rate in any community is aided by the possibility of deter­
mining easily and accurately whether given strains are likely to 
be pathogenic for man, i.e., those. belonging to Group A. It is 
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of interest to note the distribution of groups which, although 
. they are not usually associated with human disease, may occa­
sionally give rise to infection i,n man, even sometimes proving 
fatal. The records found in the literature of thirty-eight fatal 
human infections due to streptococci of groups other than A are 
shown in Table III. Compared with the incidence of fatal Group 
TABLE III 
Fatal Human Infections: Groups B to K 
Group Diagnosis Num- Remarks References ber 
Puerperal Sepsis 14 Dr. J. H. Brown also 13, 20, 36, 56, 
Endocarditis 2 reported 45 strains 105, 106, 
Terminal isolated from 2,000 117 
B pyelonephritis 1 autopsies. He con-
Terminal diabetes 1 sidered few of etio-
Meningitis 1 logical significance. 
Pneumonia 1 
-
20 
D Endocarditis 2 Non-hemolytic 112 
Proba- Ludwig's angina 1 Hemolytic 31, 89, 96, 105 
bly Endocarditis 1 Hemolytic 
D Endocarditis 6 Non-hemolytic - (numerous ·others 
8 in literature) 
Pansinusitis 1 8 
F · Pneumonia with Etiological relation-
empyema 1 ship uncertain 
Puerperal Sepsis 4 (with S. aure'U8 in 1 19, 90,105, 
G Agranulocytosis 1 case) 117 
Endocarditis 1 
-
6 
A infections, these are relatively few; and usually the strepto­
cocci in these cases have been opportunistic or terminal invaders, 
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as in puerperal sepsis, endocarditis, pyelonephritis, and agranu­
locytosis. There have also been a few cases of primary infection. 
Seven ,cultures from twenty fatal cases due to· Group B have 
been identified in our laboratory, and the remaining thirteen 
have been reported elsewhere, in the literature. In addition to 
these, Dr. J. H. Brown isolated from 2,000 autopsies at the Johns 
Hopkins Hospital, forty-five Group B strains, a few of which 
might possibly have been the primary agent, although most of 
them he considered of no etiological significance. No record has 
been found of a fatal human infection due to Group C, although 
relatively mild puerperal infections and infections of the throat 
and urinary tract do sometimes occur. Group C has also been 
reported as isolated from erysipelas, but its etiological impor­
tance here would a pear questionable ( 63). The fatal infections 
in Group D are interesting because they were apparently all due 
to the so-called enterococcus and were caused either by hemolytic 
or by non-hemolytic strains. A few deaths due to G-roups F and 
G are also recorded. No records have b�en ·found of fatal human 
infections caused by members of any of the other known groups. 
Non-hemolytic Members of the Various Serological Groups. 
The correlation between hemolytic capacity and serological 
grouping is less strict than at first supposed. The serological 
groups described were originally confined to hemolytic strepto� 
cocci, but it soon became evident that non-hemolytic strains with 
apparently identical serological characters were common in 
Group B. About half of the bovine strains studied by Stable­
forth (.121) were non-hemolytic, although there was no detect­
able immunological difference between the hemolytic and non­
hemolytic members of this group. He suggested that the pro­
duction of hemolysin might be a variable function. One such 
variation, indeed, occurred in our own experience (79). The 
parent strain was of known serological type and was highly viru­
lent for mice. Consequently, it was possible to show by immuno­
logical studies that the variant, while maintaining its virulence 
and antigenic properties, lost only its capacity to hemolyze red 
blood cells and form pigment; and these properties have never 
reappeared. 
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.As serological investigations of streptococci have been ex­
tended, non-hemolytic strains have been found with more or 
less frequency among most of the known groups. Completely 
non-hemolytic members of Group .A are rare. Todd (127) 
studied the transformation of hemolytic Group A strains into 
methemoglobin producing variants by passage through mice, and 
Fry (35) noted green-producing variants which were of the 
same serological type as hemolytic strains isolated from the same 
patient. . These strains were normally hemolytic, if grown 
anaerobically 
.Alpha, or methemoglobin producing, streptococci from bovine 
mastitis were found by Little (85) to be members of Group C. 
These non-hemolytic strains constitute a group already well-rec­
ognized by the physiological studies of S. J. Edwards (30). Cul­
turally similar, Group C streptococci have also been isolated very 
recently in England as the etiological agent in several outbreaks 
of joint-ill in lambs (7) and all belong to a single serological type. 
In Group D, non-hemoyltic varieties have been well-studied 
by Sherman and his associates (111, 112, 116) and by Graham 
and Bartley (39, 61). The non-hemolytic species, S. fecalis and 
S. liquefaciens, not only react as members of Group D, but cer­
tain strains belong to the same serological types as hemolytic
members of Group D classified biochemically as S. zymogenes.
These authors are agreed on the close antigenic relationship of
hemolytic and non-hemolytic strains of Group D.
Several investigators have found that Group D streptococci 
vary in their ability to hemolyze red cells from different species 
of animals. Thus, some strains are non-hemolytic on sheep or 
goat blood agar, but actively hemolyze red cells from the rabbit 
and from several other animal species (67). The explanation of 
this phenomenon -is not known. 
In other groups, certain non-hemolytic or doubtfully hemolytic 
strains are sometimes encountered, particularly in Groups H 
and K. 
One serological group, composed entirely of non-hemolytic 
streptococci, S. lactis, has. been described by Sherman and his 
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associates (114). The immunological reactions of S. lactis sepa­
ra�e it clearly from S1 f ecalis {belonging to Group D), which is 
in agreement with other biological reactions of these streptococci 
.previously studied by Sherman ( 115). 
The finding of close serological relationship between hemolytic 
and non-hemolytic streptococci in no way invalidates the useful­
ness of blood. agar as a differential medium in studying these bac­
teria. This is especially true 'in Group A. whei;-e few, if any, 
frankly non-hemolytic strains are known. The knowledge that 
both non-hemolytic and actively hemolytic streptococci may be­
long to th.e same serological groups directs attention to the fact 
that they have other fundamental physiological characters in 
common, which were in some cases overlooked previously on ac­
count of the special emphasis placed on the single property of 
elaborating extracellular hemolysins. 
As· an illustration, one might cite the recognized insuscepti­
bility of Group D hemolytic streptococci to the action of sul­
fonamides. With this knowledge, one would question the value 
of sulfonamide therapy of patients infected with non-hemolytic 
strains of Group D, members of which are occasionally isolated 
from cases of subacute bacterial endocarditis or urinary tract 
infections. In pyelonephritis induced · by non-hemolytic Group 
B strains, on the contrary, sulfonamide therapy would be indi­
cated. Without recognizing the essential relationship of these 
non-hemolytic strains to the serological Groups B and D, respec­
tively, the clinician might easily mistake both for S. viridans and 
apply the same treatment to both. 
Drug Fast Strains . . The failure of Group D strains to respond 
to sulfonamide therapy (9, 34) raises the question of how many 
Group A. strains may also have a natural or acquired resistance 
to these drugs. Apparently, increasing numbers of resistant 
Group A. strains are being encountered. One wonders, therefore, 
whether in addition to these naturally drug resistant strains, 
other Group A. streptococci may not acquire fastness to the drug 
and thus lead to a wide dissemination of strains resistant to these 
chemotherapeutic agel).ts. 
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Characteristics of Group'. Polysaccharides. Although the car­
bohydrates characteristic of each of the eleven serological groups 
are convenient tags for identification, the function of these so- , 
called C substances in the streptococcal cell is not understood. 
There is no group agglutination corresponding to the group pre­
cipitin reaction, and the variations in non-type-specific agglu­
tination do not appear to be correlated with the amount of 
group-specific C antibody present in the serum. 
The group-specific carbohydrate, however, in the streptococcal 
cell seems remarkably constant in amount and apparently does 
not vary with changes in virulence and in other functions. Since 
washing the streptococci yields only traces of the group-specific 
polysaccharide and since cellular disruption is required to obtain 
it in any quantity, it seems likely that this substance is not pres­
ent as a capsule but rather forms an integral part of the bacterial 
cell. 
The group-specific carbohydrate of Group A organisms has 
been studied more than the polysaccharides characteristic of 
other groups. It is not toxic for animals, and is antigenic only 
when still in combination with the cellular protein (55). On 
hydrolysis, this substance yields reducing sugars and according 
to unpublished results of Sherp ( quoted by Heidelberger and 
Kendall (55)) contains an amino sugar. The precipitin test with 
this polysaccharide provides a simple method for group identifi­
cation and differentiation of potential pathogens for a given 
animal species, but it is obvious that associated biochemical and 
cultural functions are important in the metabolism and physi­
ology of these bacteria. 
EXTRACELLULAR SUBSTANCES ELABORATED BY STREPTOCOCCI 
Although the separation of substances elaborated by micro­
organisms into extracellular and intracellular components is a 
somewhat artificial distinction, it is useful in contrasting the 
toxic constituents due to active growth of the streptococcus with 
those found only after disintegration of the bacterial cells. 
Streptolysins. We have already considered the extracellular 
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toxin which is responsible for the hemolytic properties of strep­
tococci, namely, the streptolysin, or, rath�r, the two streptolysins, 
-which Todd has shown are characteristic of Group A. Todd ( 129)
studied also the streptolysins produced by strains representative
of other groups and -found the oxygen-labile streptolysin O in
culture filtrates of certain Group C and Group G strains (Table
IV), as well as in those of all Group A strains, but the oxygen­
stable streptolysin � is quite specific for Group A. Other strep-
TABLE IV 
. Streptolysins of Group A and Other Groups 
Streptolysins eharaeteristic 
Serologieal of Group A Other strep-
group Streptolysin Streptolysin tolysins 
0 s 
A ....................................... Present Present . ........... 
C (Matt eolony) Present ............ 
G (Matt eolony) Present } 
P,...,, t but littl, 
............ 
studied 
All other groups ............ .. .......... 
tolysins, not yet identified either as to number or kind, are ob­
viously present in other serological groups of hemolytic strepto­
cocci, as indicated in the last column of Table IV. Although 
serological identification of these streptolysins has not yet proved 
feasible,. because antibodies have not been obtained for thexp., 
Todd has shown that several may be distinguished by their strik­
ing differences in susceptibility to the influence of oxygen, of 
heat and of acid (Table V). Further study may result in the 
discovery of methods suitable for antibody production specifically 
directed against these other streptolysins. 
Erythrogenic Toxins. In a few laboratories, the capacity of 
members of the various serological groups to produce erythro­
genic toxins has been determined. These toxins are responsibie 
for the rash in scarlet fever and are formed by most Group A 
-
TABLE V 
Characteristics of Streptolysins of Different Groups* 
Effect on streptolysins of 
Serological group 
·Oxygen
A, Streptolysin O ....................... ............... Reversibly 
inactivated 
A, Streptolysin S ............... ............ ... ....... -
B ........................................ ................ ........................ -
C, ("Human °) Streptolysin O ... Reversibly 
inactivated 
C, (''Animal'') -
D ......................... ........................................................ -
E ................................... ................................................. -
G, (large colony) Streptolysin 0 Reversibly 
inactivated 
* Compiled from Todd's data (129, 132).
- indicates unaffected.
Heat 
Destroyed 
Destroyed 
Moderately 
sensitive 
Destroyed 
Destroyed 
-
Destroyed 
Destroyed 
Acid 
-
Destroyed 
Moderately 
sensitive 
-
Slightly 
sensitive 
Destroyed· 
-
-
.,,,..-
Streptolysin 
neutralized 
by 
Antistreptolysin 0 
Antistreptolysin S 
-
Antistreptolysin 0 
-
-
-
.A.ntistreptolysin 0 
� 
t,,j 
� 
0
�
�
8
H 
a 
00
8
� 
"O
8
0 
a 
0 
a 
a 
H 
� 
0:, 
o;) 
Colony 
G:Poup C 
'Animal" �t:Paine "Human'' .et:Pain6 
Mucoid 
AfteP dPying: 
- Matt
. . � . .
5ma11 smooth 
(A1Po eome 
animal .stPains) 
Matt 
Fm. 1. 
Fo.P.rne 
G:Poup G 
Human 
and 
anima1 .5t�ain.5 
Matt 
Human .5tr>aine 
"Minute" 
FIG. 1. 
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strains, but not usually by members of other groups (17, 22, 23, 
. 68, 105).
Ftbrinolysin. Another extracellular -component of hemolytic 
streptococci is the fibrinolysin discovered by Tillett and Garner 
( 125). This substance is capable of dissolving the clot of normal 
human blood, and appears to be enzymatic in nature; but the 
products of lysis differ from those obtained when fibrin is di­
gested by trypsin. Among the many investigations stimulated 
by the discovery of fibrinolysin are those relating this. phenom­
enon to particular groups of hemolytic streptoco�ci. The sero­
logic�l groups which form fibrinolysin are the following: Group 
A, almost without exception; and the la.rge matt colony Group 
C and Group G strains. 
Jn order to show other relationships of the streptococci of dif­
ferent groups which produce fibrinolysin it may be of interest at 
this p-oint to discuss the different forms of Group C and Group G 
strains. Some members of these two groups are linked together 
by several common characteristics; others from wiq.ely divergent 
sources have little in common except their respective group-spe­
cific polysaccharides. In each group, several decidedly different 
colony forms occur. In Group C, some of the strains widely dis­
tributed among lower animals form large mucoid colonies, asso­
ciated with capsules (Fig. 1), or, if the mucoid substance is 
absent, they form small smooth colonies. On drying, the colony 
surface changes. from mucoid to matt.
Other Group C strains fo:r-m large matt colonies which charac­
terize the strains of human, monkey· and canine origin and also. 
some of the strains causing equine diseases other than strangles. 
They are also characteristic of the non-hemolytic Group C strains 
from bovine mastitis and joint-ill of lambs. 
Streptococci of Group G form either minute or large colonies. 
The former, described by Long and Bliss (87), is a pin point 
colony with a large area of hemolysis; the latter is a large matt 
colony indistinguishable morphologically, from the matt colonies 
of Group C, and incidentally of Group A (Fig. 2). 
Group C and Group G strains which form matt colonies are 
\ 
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also similar in their fermentation reactions with trehal ose and 
sorbitol (Table VI). Both produce the extracellular substances, 
fibrinolysin and streptolysin O. In these and in other respects, 
they also resemble Group A to such an extent that they can only 
be distinguished serologically. 'fhey show their close relationship 
to each other in that they possess a common protein antigen, but 
this is not encountered in Group A strains. This antigen some-
TABLE VI 
Distingitishing Characteristics of Gro11ps C a1ul G 
Group C Group G 
''Animal''* I "Hmn:m "t Large Colony 
Colony form Mucoid or Large matt Large matt 
small smooth 
Hemolytic zone Wide Moderate Moderate 
Capsule. + (mucoid) - -
- (small) 
Fermentation: Trehalose - + + 
Sorbitol + -
Fibriuolysin - -r + 
Streptolysiu O (Group A) . - + 
Common protein antigen -
+ + 
Animal distribution: 
llfan - + + 
Monkey - + + 
Horse T + 
Cow + + + 
Sheep 
+ + 
Dog + + 
Most other lowe1· animals + 
* T,rpe A of Ogura alld Eclw:irds, 97, %, :27. t Types 131 and B:l uf Ogurn alld Edwards. 
'':Minute'' 
(Type 1) 
Minute, smooth 
·wide
-
+ 
-
-
-
-
+ 
N) 
m 
00 
:::0 
trj 
to 
trj 
0 
0 
p,-
0 
ts 
t>-· z 
0 
trj 
ts 
tJ 
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times gives rise to confusing cross reactions between certain 
members of Groups C .and G. 'l'he cross relationship, however, is 
not connected ·with the group-specific polysaccharides of these 
l\rn groups since their respective polysaccharides when free of 
this protein are serologically distinct. 
Antisera may be prepared free of cross reactions by ab ·orption 
with appropriate matt-colony Group C or Group G strains or by 
immunizing rabbits with strains which do not contain this par­
ticular protein antigen. Examples of the latter are strains of 
guinea pig origin in Group C and "minute" colony strains in 
Group G, but certain technical difficulties sometimes interfere 
with their use as antigen. for group antisera. 
Hyaluronic Acid. The last extracellular product of hemolytic 
streptococci to be considered is the capsular substance, hyaluronic 
acid, formed by mucoid strains of Groups A and C. Kendall, 
Heidelberger and Dawson (64) isolated this substance from 
mucoid Group A l1emolytic streptococci and identified it as an 
acid polysaccharide of high molecular weight composed of acetyl­
glucosamine and glucuronic acid in equimolar concentrations. 
It £unctions neither as an antigen nor as a hapten, possibly 
because it is also normally present in the tissues of animals used 
for immunization. Sources other than bacterial from which 
hyaluronic acid has been isolated include bovine vitreous humor, 
fowl .·arcoma, pig skin, Wharton's jelly of human umbilical cord, 
.·,vnovial fluid and the pleural fluid of a patient with meso­
thelioma. 
Seastone (109) studied a similar non-antigenic mucoicl poly­
saccharide from Group C hemolytic streptococci of animal origin. 
While it has been suggested (86) that the mucoid capsular sub­
stance of hemolytic streptococci is related to their virulence, 
this has not been established-in the case of Group A. Seastone, 
on the other band, has demonstrated that the variants of Group C 
which were highly virulent for guinea pigs produced much larger 
eapsules and much more polysaccharide than did strains of low 
virulence. The different relationship to virulence of this cap­
sular substance in Groups A and C respectively, has been clearly 
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demonstrated by Hirst (57) who showed that the bacterial cells 
of both groups were decapsulated in vivo, as well as in vitro, by 
leech extract. The decapsulation apparently protected both mice 
aud guinea pigs from fatal infection with Group C streptococci, 
but wa. ineffective in mice inoculated with virulent Group A 
strains. This suggests that sub ·tances other than the mucoid 
polysaccharide are related to virulence of organisms of the latter 
group. Purther evidence indicates that in Group A, the type­
specific protein, M, is associated with virulence, and that immune 
serum containing antibodies specifically directed ag·ainst this 
substance protects mice against infection with virulent strains 
of homologous type. 
TYPE RELATIONSHIPS 
So far, this discussion has dealt primarily ·with the relationship 
between the various cellular constituents and the corresponding 
biological activities of streptococci in terms of their serological 
grouping. Let us now examine the specific types so far differ­
entiated within these groups to see what definite activities can 
be associated with them or with their determinative antigenic 
components. 
Serological '.l.'yves in Gronv A. In 1919 (25), we established 
the principle that type differentiation of epidemic strains could 
be effected by serolog·ical methods. Subsequent studies on the 
type-specific substances have definitely supported this conceptioii. 
In 1926 ( 40), Griffith attempted by slide agglutination to 
eliminate one of the great difficulties inherent in all agglutination 
techniques w.ith streptococci, namely, the difficulty of obtaining 
stable suspensions. His method also reduced the time and mate­
rial required for tests. He first established four types, and in 
1927, determined that seventy per cent of 222 scarlatina) strains 
fell into these four recognized types ( 41). Subsequentl_v, he 
continued his serological classification all(l in 1934, published 
epidemiological studies in which 27 types of hemolytic strepto­
cocci were defined ( 43). 'l'wenty-three of these types were later 
found to be members of Group A, while the other four types 
fell into other serological groups: Types 7, 20 and 21 into Group 
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C, and Type 16 into Group G. Griffith's type classification of 
Group A hemolytic streptococci has been universally adopted. 
Although most of the scarlatina[ strains of hemol:vtic strepto­
cocci are included within these types, Griffith and other investi­
gators have found that not all strains isolated from streptococcal 
infections or from carriers fall into these recognized t)'pes. In­
deed, Griffith has recently added three more; and other investi­
gators .have also described still other types, some of which appear 
to be more prevalent during certain yea.rs and in certain localities. 
Griffith pointed out that the methods employed by him, i.e., 
direct ag·glutinatiou combined with agglutinin absorption,. re­
vealed the dominant antigen which determines type specificity, 
but he did not attempt to analyze more clo ely the whole antigenic 
structure. Investigation of this latter problem has been one of 
the chief interests in our laboratory; and studies in this direc­
tion have brought to light the fa.ct that at lea.st two type-specific 
antigenic components are concerned with the type-specific reac­
tions of Group A hemolytic streptococci. These components have 
been designated M and 'l' (81). 
Relation of the 1'ype-specific Protein, M, to Colony Forrn. The 
type-specific protein, M, is the antigen primarily associated with 
virulence; and the antibodies to which it gives rise are primarily 
concerned with the specific protective action of immune sera .. 
It is present only in those variants which form mucoid or matt 
colonies (Fig. 3). Mucoid, matt and glossy variants are the 
forms ordinarily observed (126), but Dawson (24) has also ob­
tained a more degraded "rough" form, corresponding to the 
rough variants in a generalized scheme for all bacteria. The 
mucoid variant possesses the same antigens as the matt variants 
and, in addition, produces the serologically inactive capsular 
substance, hyaluronic acid (64). _The matt form may be either 
virulent or non-virul.ent, but in either state, matt variants con­
tain approximately equal amounts of the type-specific M sub­
stance (83, 134). The glossy forms are always a.virulent and 
contain little or no M substance. They sometimes form mucoid 
colonies. Immunization of animals with virulent or avirulent 
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matt variants induces the formation of anti-M precipitins and 
protective antibodies. Immunization of animals with the gloss�· 
Mucoid 
Matt 
Glo.esy 
Colony Fo.Pms 
G:0oup A 
0 
9 
FIG. 3. 
form fails to induce either protective antibodies or anti-M 
preci pi tins. 
Relation of the M Snbstance to Type-specific Reactions. In its 
relation to the pathogenic properties of the streptococcus, tbe M 
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substance appears to fm1ction in a manner somewhat parallel to 
that of the type-specific capsular polysaccharide of Pneumo­
coccus. It reacts well in the precipitin test with t�·pe-specific 
antisera, and by this mea11s a serolog'icall.,· distinct .-nbstance 
can be demonstrated for each individual t�rpe. 'rhe lVI antibod�· 
produced by animals in response to immunization with intact 
living or dead streptococci or with sol.utions of the M substance 
extl'acted from them appears responsible for t?pe-specific pro­
tection. In most types, the M antibody causes agglutination of' 
lVI-containing 01·ganisms of the same type. In at least one type, 
however (Type 1), M antibody fails to bring about agglutination 
in spite of the fact that both M antigen aud its antibody are 
present in the system and can be demonstrated by the precipitin 
reaction and by passive protection tests (81). 
'!'here is, at present, no explanation for th is failure of the M 
antibody to cause a0·glntination of 'l'ype 1 organism. when all 
conditions seem favorable for the reactiou. It is well-recognized 
that occasional strains belonging to various types ma.,· at times 
be refractory to agglutination but this inagglutinability is not 
comparable to the phenomenon described here, since Type 1 
streptococci invariably fail to be agglutinated by M antibod�·. 
That the suspensions are agglutinable in the presence of an appro­
priate ahtibody is shown wben they are brought into contact "·ith 
serum containing a second type-specific antibody directed against 
the recently discovered, so-called, 'l'' substance. Prompt and 
striking type-specific agglutination then occurs. 
Relation of the Type-specific Snbstance, T, to 1-lgglntinat·io11. 
'l he most important type-specific agyl·ntinoge11 iu all t,q)es of 
Group A appears to be the T substance. Although a.ntibocl.,· to 
this substance apparently .has no protective action, it is probabl�r 
the principal antibody respousible for t,q)e-classification based 
upon the agglutination reaction. This bl'ings up the interesting 
question oft.he functioning of two type-specific substances in 01ie 
microorganism. Unless M and 'I' are definitely correlated, one 
could imagine many possible types clue to man�� different anti­
genic corn binations. 
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CorrelaMon of JIil. ancl T Antigens in Incliviclnal Types. For­
tunately, while the number of types is indeed imposing, it is not 
often complicated by a lack of correspondence between the M 
and T antigens. Because the T antigen was unknown in 1934, 
when Griffith's report on twenty-three types of Group A hemo­
lytic streptococci appeared, it was former]�, thought that the same 
type-specific antibody was responsible for the M precipitin reac­
tion and for the agglutination reactions, which GL"iffith was 
studying. N·evertheless, representative strains and sera2 of Dr. 
Griffith's types were tested to make sure that this was true. For 
lack of suitable anti-M sera, not quite aJl types could be tested, 
but the few minor differences in. results of type-determinations 
based on the M precipitin reaction or on the slide agglutination 
technique were easily reconciled with the sing·le exception of 
Strain C203, a Group A strepto_coccus widely used for experi­
mental work. l<'or several years, it was a puzzle to understand 
why this strain appeared to be Type 1, as Dr. Griffith ( 43) classi­
fied it, b�, its agg-Jutination reactions, and yet by the M precipitin 
reactions and mouse protection tests, studied in this laborator�·, 
it reacted as Type 3. It finally became clear that this was due 
to an extra T substance not normally present in 'l'ype 3 strepto­
cocci. Thus, Strain C203 ha. both the Mand T antigens of Type 
3, and an additional T antigen of Trpe l. The latter is the 
dominant antigen effective in the agglutination reactions of this 
strain ( 81). 
From preliminanr study, it seems probable that some such 
unusual association of antigens exists in certain othel' types which 
are l1ard to differentiate by their agglutination reactions. This 
seems true in the case of Types 17 and 23 (66, 69, 99), which some 
authors have thought identical. Their M substances are, how­
ever, as distinct as those of any other type , but some strains 
of these two types undoubtedly have a complex of 'l' antigens 
not yet completely differentiated. 
Another factor, complicating the analysis of irnmnnol ogica l 
reactions of streptococci, is that the bacterial cells contain a 
2 Thc�c were gcHCJ"Ousl�- snppliecl by Dr. Griffith. 
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mixture of nucleoproteins which are usually not type-specific, 
nor even species-specific in their serological reactions. Thus, in 
the precipitin reaction and also in active and passive anaphylaxis, 
these cellular components show marked cross relationships (72, 
74-76). Reactions with them do not appear with all immune sera
and all extracts. Rabbits vary in their response to immunization
with whole. streptococci, sometimes producing these so-called
P-antibodies and sometimes failing to produce them. It has also
been found that M extracts which usually give type-specific reac­
tions may contain variable amounts of the nucleoprotein mixture,
P. For these reasons, one must constantly be on the alert to avoid
misinterpretation of results. Although it is not clear whether
the P-anti-P systems are concerned in cross agglutinations, this
possibility should always be borne in mind.
Characteristics of the Type-specific.Protein, M. Before the dis­
covery of the T substance, the protein, M, was subjected to careful 
study both of a serological and a chemical nature. This substance 
is obtained relatively free of other cellular proteins by extracting 
the streptococci with acid and heat, a procedure which renders 
most proteins insoluble; but the type-specific protein, M, is 
brought into solution by this treatment. 'l'he M substance floccu­
lates near pH 4.2, and is precipitated from neutral solution by 
the addition of alcohol. It belongs, however, to the class of 
alcohol soluble proteins ( 38), exhibiting a number of chemical 
properties in common with these substances: for example, in the 
form of the hydrochloride, the M substance is soluble in 80 
per cent alcohol. Another interesting peculiarity is the great 
rapidity with which the M substance is digested by trypsin and 
pepsin. 
In spite of its protein nature, this substance first appeared to 
be a hapten, which was capable of giving in vitro reactions. It 
did, nevertheless, induce an·aphylactic shock in guinea pigs 
passively sensitized with anti-M immune serum prepared against· 
whole streptococci. At that time, however, it was not found 
antigenic when injected into rabbits and mice, nor did it actively 
sensitize guinea pigs. 
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Recently, the work of Stamp and Hendry (123), and that of 
Mudd and his associates (93, 140) has indicated that the M 
substance in more gently treated preparations might be a true 
antigen. Dr. Hirst and I (58) also found that under better con­
ditions of extraction, the M substance is antigenic; and even in 
the form originally prepared and thought non-antigenic (73, 
7 4, 76), it was subsequently found to exhibit a certain degree of 
antigenicity if larger doses were injected. When isolated. from 
the cell, this substance is, however, a much poorer antigen than 
are the intact cells from which it was derived. 
Proteolytic Digestion of the Type-specific M Substance from 
· the Living Cell. Because proteolytic enzymes digest the type­
specific protein, M, in solutions, the effect of enzymes on living
hemolytic streptococci has been studied. Following Allison's
suggestion, several investigators have treated streptococci with
trypsin in order to transform granular, spontaneouly agglutinat­
ing cultures into diffuse, stable suspensions suitable for slide
agglutination reactions ( 66). It was observed, however, both
here and elsewhere ( 65), that these diffuse suspensions became
at the same time very susceptible to agglutination with sera
known to contain streptococcus agglutinins of a non-type-specific
nature. This seemed analogous to the change occurring in a given
strain of streptococcus when the matt form is degraded to the
glossy by the loss of its type-specific protein, M (83, 134). This
possibility was tested by trying to extract the M substance with
hydrochloric acid from matt organisms which had been subjected
to digestion with trypsin, or to obtain it from· cultures grown in
a medium containing active trypsin. It was found that the M
substance could no longer be isolated from streptococci which
had been treated in either of these ways with trypsin. The fol­
lowing facts were also observed : ( 1) The bacteria were not killed
by digestion. Plate counts of suitable dilutions of the trypsin- ·
treated and control cultures showed no significant difference in
the number of organisms in each. (2) 3Trypsin-treated strepto­
cocci were just as virulent for mice as the control cultures, appar-
s Some of these experiments were caried out by Dr. G. K. Hirst. 
HEMOLYTIC STREPTOCOCCI 277 
ently because the function of producing the M protein had not 
been affected. Consequently, when the first growth occurred in 
the peritoneal cavity, this protein was again produced. (3) 3Bac­
teria, heat-killed immediately after treatment with trypsin, failed 
to induce the formation of M antibody when injected into rab­
bits, although the controls did so uniformly. ( 4) Other proteo­
lytic enzymes were also able to digest M substance from the living 
bacteria in the same way. These experiments will be reported in 
full at another time. From this evidence, one must conclude 
that the M substance in the living bacteria is readily accessible 
to the action of proteolytic enzymes without injury to other vital 
functions of the living cells. This may be due to its possible loca­
tion near the outer surface of the streptococci. 
The Type-specific Substance, T, of Group A Streptococci. In­
vestigation of the chemical nature and immunological activity 
of the second type-specific component of Group A hemolytic 
streptococci has been greatly hampered by the failure so far to 
recover it from the bacterial cell bodies in a form suitable for 
study. 
Pathogenicity of Members of Different Types in Group A. 
Many investigators, studying the specific types of Group A hemo­
lytic streptococci in different diseases, have found a lack of corre­
lation between any particular types and the diseases in which 
they are found. Thus, scarlet fever, erysipelas, puerperal sepsis 
and other streptococcal infections may all be caused by the same 
types, or by different types at different times. Allison (1) stated 
in 1938, that the first four serological types included upwards of 
50 per cent of all cases of scarlet fever occurring in London over 
a period of ten years. In Australia, on the other hand, a differ­
ent series of types has predominated and these were not the same 
in Sydney, Melbourne or Adela�de (66). In 1931H>, in New York, 
Pauli and Coburn (99) found Types 4, 13 and 22 most common 
in throats of rheumatic fever patients; while Kuttner and Krum­
weide (70), in another group of rheumatic fever patients near 
New York in 1937-40, found still other types predominant in 
different years. Strains isolated from rheumatic fever and other 
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patients in the Rockefeller Hospital have likewise varied greatly 
from year to year. There is, apparently, no fixed relationship 
between the virulence of a type in one epidemic or locality and 
its effect at another time and place; and all gradations in severity 
of clinical manifestations may result from a single type in any 
one epidemic. Consequently, it does not seem possible that the 
type-specific substances, M and T, equally present on different 
occasions could be responsble for the divergent clinical effects, 
but rather that other unknown fluctuating factors affecting viru­
lence must be operative in both host and parasite. 
It has been demonstrated that the secondary complications in 
scarlet fever are often due to types different from those respon­
sible for the primary attacks (2, 14, 136, 137). These secondary 
complications apparently arise from cross infection in wards 
containing patients carrying many different types. It is, there­
fore, indicated that, when individual isolation is impossible, 
patients placed in a single ward should be restricted to those 
carrying the same serological type of hemolytic streptococcus. 
When this has been done, the number of secondary streptococcal 
complications has been materially reduced. Hare's recent work 
on the carrier problem also lends weight to these observations 
( 48-51). 
Serological Types in Group B. The existence of specific types 
in Group B was first established by Stableforth (121) in England, 
who found three serological types among strains from bovine 
mastitis which were sharply defined by their precipitin and 
agglutinin reactions. Reasoning by analogy with the type­
specific protein of Group A, he assumed that the type-specific 
substance in Group B was also a protein. It has developed from 
studies in our laboratory (78, 80), however, that the type-specific 
-substances in this group are polysaccharides. We also differ­
entiated four specific types on the basis of precipitin reactions
with type-specific polysaccharides obtained respectively from
each individual type, and different from the group-specific carbo­
hydrate C. Sufficiently detailed chemical studies were made of
the type-specific substances from two of these types to indicate
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that they were polysaccharides. In the other less well-studied 
types, preliminary investigation indicated that polysaccharides 
were also responsible for type-specificity. 
Correlation of antibodies against these polysaccharides with 
type-specific immunity was shown in the protection afforded mice 
infected with Types Ia or lb, if the respective antisera were ad­
ministered, and in the lack of such protection in the presence of 
antisera.of heterologous Group B types. The importance of these 
polysaccharides in virulence was also shown by a million-fold 
decrease in mouse virulence when virulent microorganisms were 
so treated that they no longer elaborated type-specific poly­
saccharides. On immunization with these degraded cultures, 
type-specific precipitins and protective antibodies were not 
formed; but precipitin for the group-specific polysaccharide, C, 
was formed much more readily than usual and in greater amount. 
These observations indicate that type-specific polysaccharides 
have a direct relationship to the antigenic properties of Group B 
streptococci, and in many instances appear to have an association 
with their pathogenicity. 
English and Australian investigators (94, 117, 122, 124) have 
been particularly active in epidemiological studies involving the 
further differentiation of Group B types, but have not identified 
the antigens involved. Employing a slide agglutination tech­
nique, they have distinguished about fourteen main and subtypes 
among bovine strains, and five more types which included 86 out 
of 100 strains of human origin. Since only one of these 100 
human strains fell into a bovine type, Simmons and Keogh (117) 
concluded that types of Group B streptococci indigenous to man 
and cattle are quite distinct and that human carriers are not, 
therefore, usually a source of infection in cattle. Brown (12, 
13) and also Little (84) in this country, however, have indicated
that the human carrier should be considered in attempts to eradi-.
cate bovine mastitis. My own study of a limited number of
strains would indicate a somewhat greater frequency of the same
specific types from human and bovine sources than that found by
Simmons and Keogh (see Table VII). The difference in opinion
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may possibly be due to the different methods used for identifying 
strains. Further study of this question is needed. 
TABLE VII 
Serological Types of Group B Streptococci Identified by Precipitin R·eaction 
Number in Types 
Source 
Ia lb II III 
Human 
Non-pathogenic ...................................... 6 14 8 20 
Associated with disease 3 3 1 2 
Etiological agent of disease* 1 1 3 6 
Total human 10 18 12 28 
Bovine 
Milk and mastitis 5 9 11 9 
Reported by Plastridge and Hartsell (102) 28 1 9 4 
Total bovine .... 33 10 20 13 
* Includes strains from some of the fatal infections recorded in Table III. 
Serological Types in Other Groups: Some progress has been 
made in several laboratories in distinguishing types within the 
other known groups. 
Group C. The :first serological types differentiated in Group C 
were the Types 7, 20, and 21 of Griffith's 1934 classification of S. 
pyogenes ( 43). These types are composed of large matt colony 
Group C strains that are probably similar culturally to the Types 
Bl and B2 of animal origin classi:fied by Ogura by means of fer­
mentation and other biochemical reactions. By .using the fer­
mentation of trehalose and sorbitol as differential tests, P. R. 
Edwards (28, 29), following the work of Ogura (97), has done· 
much toward clarifying the differences between these so-called 
"human" Group C strains and the chief "animal" Group C 
strains (Type A Ogura). One would like to know how much con­
nection there is between types determined by biochemical reac­
tions and those based upon serological reactions. Evans has 
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pointed out relationships between certain series of serological 
types in Group A and susceptibility to the action of different 
races of bacteriophage which she has studied. Australian inves­
tigators also have _concluded that definite correlation occurs be­
tween biochemical and serological reactions, at least in Groups 
A, C and G (65). 
The latter investigators have attempted to classify into sero­
logical types the Group C strains encountered in their studies: 
on the one hand, strains chiefly from the human throat, and on 
the other, strains from equine infections. Using slide agglutina­
tions, Simmons and Keogh found five main types among human 
throat strains; and Bazeley and Battle ( 5) found five main 
equine serological types which were in close agreement with the 
biochemical types, corresponding also to the biochemical types 
described previously by Ogura. Serological subtypes have been 
found, but not completely studied as yet within the main equine 
types. Most of these types have not been tested by means of the 
precipitin reaction. 
Study of type-specific substances among Group C strains has 
not progressed very far. From at least one of the Group C types 
identified by Griffith (Type 21), I have, in preliminary experi­
ments, obtained a type-specific substance which was digested by 
trypsin. No similar substance could be obtained from the mucoid 
animal strains (Type A, Ogura), although Stamp and Hendry 
(123) protected mice against infection with such a strain by
immunizing them with a protein fraction obtained in extracts.
A type-specific substance was recently found in Group C strains 
of one specific. type which caused nine separate out-breaks of 
suppurative arthritis in lambs in East Anglia, England (7). 
From extracts of these streptococci, a type-specific protein was 
separated from the group-specific polysaccharide, C. Lambs 
which recovered were immune and their blood contained a spe­
cific bactericidal substance. A further interesting feature· was 
the demonstration that these Group C streptococci were the 
methemoglobin producing, or alpha type, similar to the alpha
Group C strains from bovine mastitis. The authors draw atten-
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tion to the similarity of the streptococci from joint-ill to these 
bovine strains and to the Group C strains of human origin. With 
none of the other human or animal Group C strains at their dis­
posal were they able to induce joint-ill in lambs but none were 
of the same serological type as those from joint-ill. 
Groups F and G. Both the precipitin and slide agglutination 
techniques have been applied by Bliss (8) with equal success to 
the differentiation of serological types among the "minute" 
hemolytic streptococci of Groups F and G. In Group F, two 
large and well-defined types have been found, and a third smaller 
and less distinct type seemed to be present. The ''minute'' 
strains belonging to Group G form one serological type, with a 
type-specific antigen which is so similar serologically to that of 
the Type 1, Group F, strains, as to suggest that these antigens 
may be identical chemically. 
As already implied, these Type 1 strains of Groups F and G 
differ sharply in their group-specific antigens, the "C" poly­
saccharides, which are entirely characteristic of their respective 
groups (77). Serological relationships of this sort, based on 
chemical similarity of the antigens concerned, are not uncommon 
among bacteria, or even among apparently unrelated forms of 
life. 
Simmons and Keogh (117), using slide agglutinations only, 
have investigated the serological types of 78 Group G strains of 
human origin isolated in Australia, and have found evidence of 
more than one type in the "minute" strains studied by them, 
and of three types among the large colony strains. 
Miscellaneous Information Concerning Types in Various 
Groups. In our own laboratory, some evidence of the occurrence 
of specific types based on the precipitin reaction has been encoun­
tered among other groups as follows: Group D, 3 distinct types; 
Group E, 1; Group F, 2; Group G, 1; Group K, 1. Strains un­
classified as to type remain in all groups. Houston and his col­
laborators have also indicated the finding of specific types among 
the enterococci (Group D) although the details have not, I think, 
been published (39, 61, 62). 
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In none of the types enumerated among groups other than A 
and B has the type-specific substance been isolated and studied 
except in crude extracts. Their behavior, however, suggests that 
the type-specific antigens in all except Groups A and C, are prob­
ably polysaccharides, but further study of these substances is 
needed to determine their chemical nature. 
Overlapping Immunological Relationships. Overlapping im­
munological reactions have been observed with increasing fre­
quency not only among bacteria but also in other natural sources 
widely separated generically. Although such cross reactions usu­
ally indicate genetic relationships, it also sometimes happens that 
no consistent relationship is apparent. However, where chemical 
data are available, it has been found that serological similarities 
are always based on chemical likenesses, whether the determina­
tive substances are derived from related or unrelated sources. 
Examples of this phenomenon are fairly common among hemo­
lytic streptococci, and these cases suggest genetic relationships. 
These overlapping reactions are comprehensible because related 
chemical components have been isolated from the streptococci in 
several of these instances. Frequently, the overlapping speci­
ficity appears dependent on chemical relationships between type­
specific polysaccharides, as between two types in Group B (78, 
80). Another example occurs between two types, one of which is 
in Group F, the other in Group G (8). More obscure cross rela­
tionships, not always reciprocal, have been observed. These in­
clude agglutinations of certain Group B and C strains in sera of 
certain Group A types. Finally, some of the cross agglutinations 
in Group A which were formerly confusing are now understood 
because of knowledge concerning the T substance. 
Summary of Group and Type Siibstances. In order to leave 
with you a clear conception of t�e Group and Type antigens so 
far known, I· have prepared a table showing somewhat arbi­
trarily the simpler relationships of these substances. The first 
and second columns indicate that each group has an individual 
polysaccbaride, the C substance, specific for that group. The 
last three columns show the substances concerned with type-speci-
TABLE VIII 
Group and Type Specific Antigens of Hemolytic Streptococci 
Group specificity Type specificity 
Serological Group specific Specific types Type specific substances 
group '' C'' substances recognized Designated Chemical nature 
A At least 30 "M" Proteins 
"T" Undetermined 
B Polysaccharides immun- Several "8" Polysaccharides Substances chemically 
C ologically distinct for Several No symbol Proteins and immunologically 
each group distinct for each type 
Remaining 
groups Several "8" Polysaccharides 
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fl.city within each group and what is known of their chemical 
nature. Thus, in each of the 30 odd types of Group A strepto­
cocci, an individual type-specific protein, M, is associated with 
virulence; and the antibodies to which this type-specific sub­
stance gives rise are responsible for the serological and protec­
tive action of immune sera. The second type-specific substance, 
T, in Group A, is known chiefly as an agglutinogen, usually one 
T substance for each type; its chemical nature is not yet deter­
mined. In Group B, the type-specific substance of each indi­
vidual type is a polysaccharide, designated S, and appears to be 
solely responsible for type-specificity. In at least one type within 
Group C, a protein is the type-specific substance, and proteins 
also appear to be the type-specific substances in two other types 
within this group. In mucoid strains of this group, the non­
antigenic mucoid polysaccharide plays an important part in viru­
lence, but is not apparently associated with type-specificity. 
In other groups, less is known about the type-specific sub­
stances, but the evidence suggests that polysaccharides are 
chiefly concerned. 
SUMMARY 
In summarizing the results of these immunochemical studies 
of hemolytic streptococci, one might question the wisdom of dis­
secting the microorganism so completely rather than studying its 
functions as a whole. In complicated systems where the inter­
actions between bacteria and host are being investigated, much 
information can be obtained by studying the various components 
separately. 
At present, the biological function of the group-specific poly­
saccharide C is not understood. Although we are unaware of 
how this substance contributes to the metabolism of the bacterial 
cell, it is useful as a meani, of identifying the origin of the par­
ticular streptococcus from which it was derived. In this way, 
strains pathogenic for man can be distinguished from those which 
are of animal origin and only rarely, if ever, induce disease in 
human beings. Other related characteristics can also be sur­
mised by identifying this particular cell component. 
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The function of the type-specific substance is better understood 
than is that of the group-specific polysaccharides. It seems cer­
tain that the type-specific protein, M, is related to the virulence� 
of Group A streptococci; and the host's reaction in producing 
antibodies against the M substance is one of the important means 
of protection against infection with these cocci. The type-specific 
activities of Group A strains are chiefly referable to the M pro­
tein, except that type-specific agglutination is now known to be 
related primarily to another cellular component of unknown 
chemical composition, the T substance. Antibodies engendered 
by this substance apparently do not exert any protective action 
in combatting infection. Whether the M and T substances exist 
in combined or separate form in the cell is still to be determined; 
but the presence of T substance, both in matt variants and their 
avirulent glossy derivatives, explains why Group A hemolytic 
streptococci may lose their type-specific M protein and still ex­
hibit type-specific agglutination. Before the T component of the 
type-specific complex was known, it was difficult to explain the 
type-specific agglutination of strains producing little, if any, M 
protein. Even though not all of the immunological reactions of 
hemolytic streptococci are understood, the general pattern has 
become much clearer since this part of it has been elucidated. 
The examples mentioned indicate the direction of these studies 
of hemolytic streptococci and emphasize the relationship of spe­
cific cellular components to the biological activities of the whole 
microorganism. 
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